openPR Logo
Press release

Vaccines Market to Attain Value of Around US$48.0 Bn by the End of 2025

12-05-2018 05:32 PM CET | Health & Medicine

Press release from: Transparency Market Research

Vaccines Market to Attain Value of Around US$48.0 Bn by the End

The global vaccines market as per a report by Transparency Market Research (TMR) exhibits a highly competitive environment owing to presence of several players. In order to gain edge over rivals, several leading companies are investing in research and development initiatives. Furthermore, many companies are focusing on product launches, which could intensify the competition further in the coming years.

Some of the major players in the global vaccines market are Sanofi Pasteur SA, GlaxoSmithKline plc. Pfizer, Inc., Serum Institute of India Ltd, Merck & Co., Inc., Emergent BioSolutions Inc., Janssen Pharmaceutical Company, CSL Ltd, Mitsubishi Tanabe Pharma Corporation, and Novavax AB.

View Report -
https://www.transparencymarketresearch.com/global-vaccine-market.html

The global vaccines market was valued at US$28.0 bn in 2016 and is expected to exhibit a CAGR of more than 6.0% over the forecast period from 2017 to 2025 to attain value of around US$48.0 bn by the end of 2025. On the basis of route of vaccination, the market is dominated by the injectable vaccines owing to high adoption of injectable vaccines for its convenience, effectiveness, and ease. North America is anticipated to dominate the global market for vaccines thanks to continuous funding for research activities and vaccine development in the region. However, Asia Pacific is projected to record a faster growth with higher rate over the forecast period, owing to increasing prevalence of diseases such as tuberculosis, malaria, and dengue in the region.

Vaccines offer immunity against a particular disease. Vaccines contain a resembling agent, which stimulates the immunity system to distinguish the foreign object and to destroy them. Better efficiency and functionality of these vaccines are boosting their adoption for treatment of various diseases, which is likely to boost the global market for vaccines. Additionally, rising incidences of infectious diseases such as influenza, pneumonia, malaria, meningococcal meningitis, hepatitis, measles, HIV, dengue, and diphtheria are increasing globally. This is major factor boosting need for the proper vaccinations to treat the diseases which in turn driving growth of the global vaccines market.

Request to View Sample of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21

Rising government initiatives favoring vaccination drives worldwide is bolstering growth of the vaccines market. In addition to this, key players are focus on adopting new technologies for vaccine delivery, which are easy, quick, and safe substitutes for the conventional methods. This strategy has immense potential to increase patient acceptability and also increase the rates of immunization

However, high cost experienced in vaccine development and production is key factor hampering growth of the global market for vaccines. In addition, presence of stringent regulations and policies for the practice of vaccine is expected to hamper the market in the years to come.

Nevertheless, the increase in investment from key players and local governments, as well, to improve and increase research and development activities in the field of vaccines is creating opportunities for growth of vaccines market, significantly.

Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=21

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vaccines Market to Attain Value of Around US$48.0 Bn by the End of 2025 here

News-ID: 1419797 • Views:

More Releases from Transparency Market Research

Global Ophthalmic Sutures Market to Reach USD 1.3 Billion by 2034, Driven by Rising Ocular Disease Burden and Advancements in Eye Surgery
Global Ophthalmic Sutures Market to Reach USD 1.3 Billion by 2034, Driven by Ris …
The global Ophthalmic Sutures Market is experiencing significant momentum as demand surges for improved ophthalmic surgical outcomes amid increasing incidences of ocular disorders worldwide. According to the latest industry assessment, the market, valued at US$ 629.0 million in 2023, is projected to expand at a CAGR of 6.5% between 2024 and 2034, ultimately reaching US$ 1.3 billion by 2034. This comprehensive press release provides an in-depth examination of market size, trends,
Global Ophthalmology PACS Market to Reach USD 359.8 Mn by 2034, Driven by Rising Ophthalmic Disease Burden and Advances in Diagnostic Imaging
Global Ophthalmology PACS Market to Reach USD 359.8 Mn by 2034, Driven by Rising …
The global Ophthalmology PACS (Picture Archiving and Communication System) Market is poised for strong expansion over the next decade as the industry continues transitioning toward digital, AI-enabled ophthalmic imaging management solutions. According to recent market assessments, the global Ophthalmology PACS market valued at US$ 167.8 Mn in 2023 is projected to grow at a CAGR of 7.3% from 2024 to 2034, ultimately reaching US$ 359.8 Mn by the end of
Global Ophthalmology Surgical Devices Market Set to Reach USD 12.1 Billion by 2031 Amid Rising Incidence of Cataracts and Glaucoma
Global Ophthalmology Surgical Devices Market Set to Reach USD 12.1 Billion by 20 …
The global Ophthalmology Surgical Devices Market is poised for steady expansion, driven by rising demand for advanced surgical systems, increasing prevalence of cataracts and glaucoma, and accelerating adoption of minimally invasive techniques. The market was valued at US$ 8.1 billion in 2022 and is projected to reach US$ 12.1 billion by 2031, expanding at a CAGR of 4.7% from 2023 to 2031. Unlock crucial data and key findings from our Report
Global Opioid Use Disorders Market to Reach US$ 8.8 Billion by 2034, Driven by Rising Addiction Rates and Government Initiatives
Global Opioid Use Disorders Market to Reach US$ 8.8 Billion by 2034, Driven by R …
The global Opioid Use Disorders (OUD) Market is set for strong expansion over the next decade, rising from US$ 3.2 billion in 2023 to an estimated US$ 8.8 billion by 2034, according to the latest industry assessment. The market is projected to grow at a CAGR of 9.9% from 2024 to 2034, supported by increasing government funding, rising public awareness, and the escalating prevalence of opioid addiction across all major

All 5 Releases


More Releases for Vaccines

Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC. Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,